NRIX241115C35000
- 0.28
- -0.12-30.00%
Nurix Therapeutics Newsroom
A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $29 to $41
Analysts Are Bullish on Top Healthcare Stocks: Nurix Therapeutics (NRIX), Ascendis Pharma (ASND)
Nurix Therapeutics Analyst Ratings
Promising Prospects for Nurix Therapeutics: Buy Rating Backed by Strong Data on NX-5948
Nurix Therapeutics Presents Positive Results From the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
Express News | Nurix Therapeutics Expands Its Board of Directors With the Addition of Drug Commercialization Expert Anil Kapur
Press Release: Nurix Therapeutics Expands Its Board of Directors With the Addition of Drug Commercialization Expert Anil Kapur
Oppenheimer Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $35
Nurix Therapeutics Price Target Raised to $35 From $30 at Oppenheimer
J.P. Morgan Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Cuts Target Price to $31
A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $29 to $35
Express News | Nurix Therapeutics Inc : Morgan Stanley Raises Target Price to $16 From $15
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nurix Therapeutics (NRIX) and PTC Therapeutics (PTCT)
Optimistic Buy Rating for Nurix Therapeutics Based on Promising NX-5948 Drug Candidate and Strategic Collaborations
Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Nurix Therapeutics Is Maintained at Outperform by RBC Capital
A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $26 to $35
RBC Trims Price Target on Nurix Therapeutics to $26 From $27, Keeps Outperform, Speculative Risk
Truist Financial Remains a Buy on Nurix Therapeutics (NRIX)
Nurix Therapeutics Price Target Maintained With a $29.00/Share by Needham